Zosano Pharma Corp :Zosano Pharma Provides Corporate Update.Zosano Pharma Corp - Recently Implemented An Additional Workforce Reduction Impacting Approximately 40% Of Its Remaining Employees.Zosano Pharma Corp - In Order To Preserve Its Capital And Cash Resources, Zosano Has Suspended Its M207 Program.Zosano Pharma Corp - Suspended Gmp Manufacturing Operations At Its Fremont, California Facility.Zosano - Suspended Activities At Its Third-Party Contract Manufacturing Organizations Related To Qualification Of Commercial Manufacturing Equipment.Zosano Pharma Corp - Currently Evaluating Its Long-Lived Assets For Impairment.Zosano Pharma Corp - Remaining Feasibility Study With A Pharmaceutical Partner Is Expected To Conclude This Quarter.Zosano Pharma Corp - As Of April 26, 2022, Company Had Approximately $11.4 Million Of Cash And Cash Equivalents.Zosano Pharma - Continuing To Work With Sierraconstellation Partners As Independent Financial Advisor To Assist In Exploring Strategic Alternatives.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。